Learn, Analyse & Invest
only with
only with
+91
Download Orca
Shelter Pharma Ltd.
Shelter Pharma
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹50.48 Cr.
| EX-Date | Purpose |
|---|---|
| 10 11 2023 | Half Yearly Results |
| 30 10 2024 | Half Yearly Results |
| 08 01 2025 | Inter alia, to consider the proposal for fund raising through the issue of equity shares of the Company on Rights Basis to existing equity shareholders of the Company, as may be permitted under applicable law, subject to such regulatory and/or statutory approvals, as may be applicable |
| 29 05 2025 | Audited Results |
| 18 06 2025 | Inter-alia, to consider and approve:- 1. re-evaluate the proposal for fund raising through the issue of equity shares of the Company on Rights Basis. 2. To consider raising of funds through issue of Warrants or such other Securities which may or may not be Convertible into Equity Shares of the Company |
| 26 06 2025 | Preferential Issue of shares & Inter alia, to consider, evaluate and approve: 1. To consider and approve to raise funds by way of issue of Convertible Equity Warrants convertible into the Equity Shares of face value of Rs. 10/- each of the Company, the proposed Allottees of such Warrants, Number of Warrants, Issue Price and other relevant details relation to Warrants, by way of Preferential Issue and Private Placement in one or more tranches, subject to applicable law and requisite approvals including approval of the Shareholders of the Company, Government / Regulatory / Statutory approvals, as may be applicable. 2. To decide on convening of Extra Ordinary General Meeting to take necessary approvals of the Shareholders for Issue of convertible securities as warrants. 3. To transact any other matter with permission of the Chairperson |
| 02 09 2025 | Final Dividend & A.G.M. |
| 10 11 2025 | Half Yearly Results |
News
